Literature DB >> 9451724

High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains.

P Rosel1, B Arranz, J Vallejo, M Oros, J M Menchón, P Alvarez, M A Navarro.   

Abstract

Specific binding of [3H]imipramine and [3H]paroxetine was simultaneously examined in human brains (frontal cortex, temporal cortex, cingulate cortex, hypothalamus, hippocampus and amygdala) from 11 controls and 11 depressed suicide victims. A single saturable high affinity site was obtained for both radioligands. Age was not related to significant changes in [3H]imipramine and [3H]paroxetine binding parameters, which indicates the stability of the brain serotonergic system with increasing age. A major finding of the present study concerns the existence of a significant decrease in the maximum number (Bmax) of [3H]imipramine binding sites in hippocampus from depressed suicides as compared with the control group, without changes in the binding affinity (Kd). In contrast, when [3H]paroxetine was used as radioligand, no changes in either Bmax or Kd were detected in any of the brain regions studied. These findings suggest that [3H]imipramine may be a better marker than [3H]paroxetine when alterations in the presynaptic serotonergic uptake site are to be detected.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9451724     DOI: 10.1007/BF01285560

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  39 in total

1.  Age stability of human brain 5-HT terminals studied with [3H]paroxetine binding.

Authors:  A Andersson; I Sundman; J Marcusson
Journal:  Gerontology       Date:  1992       Impact factor: 5.140

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  Different components of 3H-imipramine binding in rat brain membranes: relation to serotonin uptake sites.

Authors:  M Gobbi; C Taddei; T Mennini
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

4.  Regional distribution of [3H]imipramine binding in rat brain.

Authors:  M Palkovits; R Raisman; M Briley; S Z Langer
Journal:  Brain Res       Date:  1981-04-06       Impact factor: 3.252

5.  Demonstration of specific high affinity binding sites for [3H] imipramine in human brain.

Authors:  M Rehavi; S M Paul; P Skolnick; F K Goodwin
Journal:  Life Sci       Date:  1980-06-30       Impact factor: 5.037

6.  Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.

Authors:  S Z Langer; A M Galzin; M F Poirier; H Loo; D Sechter; E Zarifian
Journal:  J Recept Res       Date:  1987

7.  Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior.

Authors:  G N Pandey; S C Pandey; Y Dwivedi; R P Sharma; P G Janicak; J M Davis
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

Review 8.  Neurochemical alterations of serotonergic neuronal systems in depression.

Authors:  S C Risch; C B Nemeroff
Journal:  J Clin Psychiatry       Date:  1992-10       Impact factor: 4.384

9.  5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders.

Authors:  J O Marcusson; I Alafuzoff; I T Bäckström; E Ericson; C G Gottfries; B Winblad
Journal:  Brain Res       Date:  1987-11-03       Impact factor: 3.252

10.  Tritiated imipramine binding sites are decreased in the frontal cortex of suicides.

Authors:  M Stanley; J Virgilio; S Gershon
Journal:  Science       Date:  1982-06-18       Impact factor: 47.728

View more
  4 in total

Review 1.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 2.  Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.

Authors:  Louise M Paterson; Robin J Tyacke; David J Nutt; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200

3.  Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects.

Authors:  Hymie Anisman; Lisheng Du; Mikos Palkovits; Gabor Faludi; Gabor G Kovacs; Peter Szontagh-Kishazi; Zul Merali; Michael O Poulter
Journal:  J Psychiatry Neurosci       Date:  2008-03       Impact factor: 6.186

Review 4.  5-HT radioligands for human brain imaging with PET and SPECT.

Authors:  Louise M Paterson; Birgitte R Kornum; David J Nutt; Victor W Pike; Gitte M Knudsen
Journal:  Med Res Rev       Date:  2011-06-14       Impact factor: 12.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.